Acyclovir and Timoptic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Timoptic (timolol maleate). Common drug interactions include abdominal abscess among females and candidiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Timoptic. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Timoptic?

Timoptic has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 4,247 Timoptic users. Check the latest studies of Timoptic.



On Jul, 07, 2026

18 people who take Acyclovir and Timoptic together, and have interactions are studied.

Acyclovir and Timoptic drug interactions.

What are the common drug interactions of Acyclovir and Timoptic, by gender? *:

female:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Abdominal pain lower
  3. Abscess intestinal (collections of pus-intestinal)
  4. Adrenal disorder
  5. Anaemia (lack of blood)
  6. Anxiety
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Arthralgia (joint pain)
  9. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  10. Atelectasis (partial or complete collapse of the lung)

male:

  1. Candidiasis (candidiasis or thrush is a fungal infection)
  2. Cough
  3. Atelectasis (partial or complete collapse of the lung)
  4. Balance disorder
  5. Benign prostatic hyperplasia (benign enlargement of the prostate)
  6. Blindness unilateral
  7. Blood immunoglobulin a decreased
  8. Blood immunoglobulin g decreased
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  10. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)

What are the common drug interactions of Acyclovir and Timoptic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

50-59:

  1. Benign prostatic hyperplasia (benign enlargement of the prostate)
  2. Blindness unilateral
  3. Blood immunoglobulin a decreased
  4. Blood immunoglobulin g decreased
  5. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  6. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  7. Candidiasis (candidiasis or thrush is a fungal infection)
  8. Cellulitis (infection under the skin)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colonic polyp (extra part of colon tissue grow in intestine)

60+:

  1. Anaemia (lack of blood)
  2. Cough
  3. Adrenal disorder
  4. Anxiety
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Balance disorder

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 8 people, 44.44%
  2. Multiple Myeloma (cancer of the plasma cells): 4 people, 22.22%
  3. Headache (pain in head): 2 people, 11.11%
  4. Weakness: 1 person, 5.56%
  5. High Blood Pressure: 1 person, 5.56%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%
  7. Back Pain: 1 person, 5.56%
  8. Blood Iron Increased: 1 person, 5.56%
  9. Bone Pain: 1 person, 5.56%
  10. Breast Lump (localized swelling that feels different from the surrounding breast tissue): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Timoptic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timoptic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and timolol maleate (the active ingredients of Acyclovir and Timoptic, respectively), and Acyclovir and Timoptic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: